CORE LABORATORIES N.V. Asset Impairment Charges
CORE LABORATORIES N.V. reported Asset Impairment Charges of $0 for the 12-month period ending 2022-12-31, per its 10-K filed 2023-02-10.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AssetImpairmentCharges · last filed 2023-02-10
- CORE LABORATORIES N.V. asset impairment charges for the quarter ending 2021-12-31 was $0.00.
- CORE LABORATORIES N.V. asset impairment charges for the quarter ending 2021-09-30 was $0.00.
- CORE LABORATORIES N.V. asset impairment charges for the quarter ending 2020-12-31 was $0.00.
- CORE LABORATORIES N.V. asset impairment charges for the quarter ending 2020-09-30 was $0.00.
- CORE LABORATORIES N.V. asset impairment charges for fiscal 2022 was $0.00.
- CORE LABORATORIES N.V. asset impairment charges for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CORE LABORATORIES N.V. asset impairment charges for fiscal 2020 was $122.20M.
- CORE LABORATORIES N.V. asset impairment charges for fiscal 2019 was $0.00.
| Period end | Asset Impairment Charges 3 month | Asset Impairment Charges 6 month | Asset Impairment Charges 9 month | Asset Impairment Charges 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-02-10 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $0.00 derived: sum of 2 quarters · filed 2023-02-10 | $0.00 10-K · filed 2023-02-10 | |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $0.00 10-Q · filed 2021-10-29 | ||
| 2021-06-30 | $0.00 10-Q · filed 2021-07-30 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-10 | $0.00 derived: sum of 2 quarters · filed 2023-02-10 | $0.00 derived: sum of 3 quarters · filed 2023-02-10 | $122.20M 10-K · filed 2023-02-10 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-29 | $0.00 derived: sum of 2 quarters · filed 2021-10-29 | $122.20M 10-Q · filed 2021-10-29 | |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | $122.20M 10-Q · filed 2021-07-30 | ||
| 2020-03-31 | $122.20M 10-Q · filed 2021-04-23 | |||
| 2019-12-31 | $0.00 10-K · filed 2022-02-10 | |||
| 2017-12-31 | $0.00 10-K · filed 2018-02-12 | |||
| 2016-12-31 | $0.00 10-K · filed 2018-02-12 | |||
| 2015-12-31 | $5.20M 10-K · filed 2018-02-12 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-02-10 | |||
| 2013-12-31 | $0.00 10-K · filed 2016-02-12 |